(Q38230196)

31 August 2017

title

Genetic testing today (English)

1 reference

31 August 2017

David Euhus

1

1 reference

31 August 2017

publication date

17 July 2014

1 reference

Annals of Surgical Oncology

31 August 2017

published in

1 reference

31 August 2017

volume

21

1 reference

31 August 2017

issue

10

1 reference

31 August 2017

page(s)

3209-3215

1 reference

STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES: INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Linkage of early-onset familial breast cancer to chromosome 17q21

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Quality assessment of the human genome sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Identification of the breast cancer susceptibility gene BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

The heritability of breast cancer: a Bayesian correlated frailty model applied to Swedish twins data

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Inherited susceptibility to common cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

A breast cancer prediction model incorporating familial and personal risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

CHEK2 is a multiorgan cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Variation in telangiectasia predisposing genes is associated with overall radiation toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Radiotherapy in the treatment of hereditary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Exemestane for breast-cancer prevention in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Risk-reducing appendectomy and the elimination of BRCA1-associated intraperitoneal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Nipple-sparing mastectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Management of BRCA1/2 associated breast cancer: a systematic qualitative review of the state of knowledge in 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

RAD51C-deficient cancer cells are highly sensitive to the PARP inhibitor olaparib

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Genetic Susceptibility to Prostate, Breast, and Colorectal Cancer among Nordic Twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

Germline RAD51C mutations confer susceptibility to ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3906-0

10.1245/S10434-014-3906-0

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1013241291

0 references

1 reference